Upstream Works, Aceyus to pioneer customer experience solutions

Upstream Works, Aceyus to pioneer customer experience solutions

Published: Just now By Mateen Dalal

Customer Experience (CX) is vital for companies to understand the mindset of their clients. Industries are actively investing in customer experience solutions to stay ahead in competition. Companies are also partnering w....

AstraZenecas Farxiga gets fast track status to treat heart failure

With heart related issues and number of people diagnosed with heart failure increasing substantially, the need to find a solution to this problem is growing considerably. Advanced technology, equipment and pharmaceutical companies are conti....

Patient data from Oncopeptides’ Phase 2 trial to be showcased at IMW

Patients having Relapsed-refractory multiple myeloma (RRMM) along with extramedullary disease (EMD) will be treated by Oncopeptides AB. In the company’s HORIZON trial, a cumulative response rate of 23% was attained with dexamethaso....

Vertex- Scottish govt. sign cystic fibrosis treatment access contract

As part of the 5-year agreement, Vertex will also be collecting real world data on these medicines. Vertex Pharmaceuticals Incorporated has reportedly announced that Scotland based patients suffering from cystic fibrosis will now be eligib....

Japan’s SoftBank amid plans to invest in venture capital funds

The conglomerate plans to mark its presence in Latin America by investing in venture capital funds, with a strategy to deploy nearly $500 million in five to 10 funds. SoftBank Group Corp., a multinational conglomerate based out of Tokyo, r....

Lyft partners with SambaSafety to improve driver monitoring solution

The venture will offer real-time alerts of bad driver activity, thorough state motor vehicle record data and Driver scoring designed according to Lyft's safety standards. SambaSafety, the leading provider of mobility risk data solution....

Grünenthal and Mesoblast partner to develop innovative cell therapy

Grünenthal will own the exclusive commercialization rights of allogeneic cell therapy candidate MPC-06-ID in Latin America and Europe. Grünenthal, a pharmaceutical company that offers various therapies like pain management, have ....